NRG HN006
Trial Overview
Official Title
Randomized Phase II/III Trial of Sentinel Lymph Node Biopsy Versus Elective Neck Dissection for Early-Stage Oral Cavity CancerRandomized Phase II/III Trial of Sentinel Lymph Node Biopsy Versus Elective Neck Dissection for Early-Stage Oral Cavity Cancer
Study Purpose
To see if neck and shoulder function and pain are better after SLN biopsy surgery compared to the usual approach and to see if SLN biopsy surgery is as good as the usual approach in extending your time without cancer.
Diagnosis
Patients who have early-stage oral cavity cancer and are having neck dissection surgery.Eligibility
Early stage SCC T1-2N0 of oral cavity with planned surgery.
PET/CT required.
MUST be node negative.
Excisional biopsies of primary tumor permitted.
Patients must sign an approved informed consent and authorization permitting release of personal health information.
Intervention
This study has 2 study groups.
- Group 1: Patients will have the study approach called SLN biopsy surgery.
- Group 2: Patients will get the usual approach used to treat this type of cancer, END surgery. The END surgery removed many of the lymph nodes in your neck and then tests them for cancer.
For more information, visit ClinicalTrials.gov